Literature DB >> 30127056

Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis.

Ricardo J O Ferreira1,2, Mwidimi Ndosi3,4, Maarten de Wit5,6, Eduardo José Ferreira Santos1,2,7, Cátia Duarte1,8, Johannes W G Jacobs9, Pedro M Machado10,11, Désirée van der Heijde12, Laure Gossec13,14, Jose A P da Silva1,8.   

Abstract

Entities:  

Keywords:  disease activity; inflammation; patient perspective; rheumatoid arthritis; treatment

Mesh：

Substances：

Year:  2018        PMID： 30127056     DOI： 10.1136/annrheumdis-2018-214199

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.

Authors:  Ana-Maria Orbai; Jamie Perin; Clémence Gorlier; Laura C Coates; Uta Kiltz; Ying Ying Leung; Penelope E Palominos; Juan D Cañete; Rossana Scrivo; Andra Balanescu; Emmanuelle Dernis; Sandra Tälli; Adeline Ruyssen-Witrand; Martin Soubrier; Sibel Aydin; Lihi Eder; Inna Gaydukova; Ennio Lubrano; Umut Kalyoncu; Pascal Richette; M Elaine Husni; Josef S Smolen; Maarten de Wit; Laure Gossec
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-12       Impact factor: 4.794

Review 2.  Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence.

Authors:  Laura C Coates; Maarten de Wit; Amy Buchanan-Hughes; Maartje Smulders; Anna Sheahan; Alexis R Ogdie
Journal:  Rheumatol Ther       Date:  2022-04-12

3.  Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time.

Authors:  Niels W Boone; Alexandre Sepriano; Paul-Hugo van der Kuy; Rob Janknegt; Ralph Peeters; Robert B M Landewé
Journal:  RMD Open       Date:  2019-01-22

4.  Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patients.

Authors:  Jose Antonio Pereira da Silva; Laure Gossec; Catia Duarte; Eduardo José Ferreira Santos; Ricardo J O Ferreira; Tore K Kvien; Maxime Dougados; Maarten de Wit
Journal:  RMD Open       Date:  2021-02

5.  Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis.

Authors:  Serena Bugatti; Ludovico De Stefano; Antonio Manzo; Garifallia Sakellariou; Blerina Xoxi; Carlomaurizio Montecucco
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-05-22       Impact factor: 5.346

6.  Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.

Authors:  Niels W Boone; Alexandre Sepriano; Paul-Hugo van der Kuy; Rob Janknegt; Ralph Peeters; Robert B M Landewé
Journal:  RMD Open       Date:  2019-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.